Investor Relations

CG/ESG Reports

The Board is committed to maintain a high standard of corporate governance practices. The Group believes that high standard of corporate governance provides a framework and solid foundation for achieving, attracting and retaining the high standard and quality of the Group’s management, promoting high standards of sound internal control, accountability and transparency to all shareholders of the Company and also meeting the expectations of the Group’s various stakeholders.

Please refer to the Corporate Governance Report section of our latest Annual Report for more detailed elaboration of the Group’s corporate governance practices and structure.

IR Contact

China Regenerative Medicine International Limited


10/F, Dah Sing Financial Center, 108 Gloucester Road, Wan chai, Hong Kong


T: +852 3966 8388 |

F: +852 2802 0026